Human Amniotic Fluid

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Human Amniotic Fluid
Accession Number
DB15871
Description

Human amniotic fluid is the liquid surrounding the human embryo and fetus.1 Physically, the fluid provides protection through cushioning. Chemically, the fluid provides protection through its inherent antibacterial properties. The fluid contains carbohydrates, proteins, lipids, electrolytes, urea, immunoglobulins, growth factors, and vitamins.1,2

Type
Biotech
Groups
Investigational
Synonyms
Not Available
External IDs
  • Human Amniotic Fluid

Pharmacology

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Indication
Not Available
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics
Not Available
Mechanism of action

Human amniotic fluid was seen to reduce inflammation in lungs of COVID-19 patients through a decrease in C-reactive protein in a study.2 However, the mechanisms of action of this therapy are unclear. Currently, human amniotic fluid is being investigated against COVID-19.

Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Classification
Not classified

Chemical Identifiers

UNII
6SQ06FQ2GH
CAS number
Not Available

References

General References
  1. National Center for Biotechnology Information: Embryology, Amniotic Fluid [Link]
  2. University of Utah Health: AMNIOTIC FLUID COULD REDUCE ACUTE SYMPTOMS, LONG-TERM RISKS OF COVID-19 [Link]
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2Not Yet RecruitingTreatmentVenous Stasis Ulcers (VSU)1
1, 2RecruitingTreatmentCoronavirus Disease 2019 (COVID‑19) / SARS CoV-21
0RecruitingTreatmentCoronavirus Disease 2019 (COVID‑19) / SARS CoV-2 Infection1
Not AvailableUnknown StatusTreatmentFatty Atrophy / Rotator Cuff Syndrome1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on September 21, 2020 17:22 / Updated on September 22, 2020 13:00